Like in heterologous infectious challenges, CD4+ TIA cells are thus preferentially recruited to the site of autoimmune inflammation, where they can be activated in a TCR-independent manner to produce IFN-γ and contribute to autoimmune disease. This evidence concerns the gene IFNG and autoimmune disease.